They found that many immune checkpoint molecules, such as CTLA-4, PD-L1 and PD-L2, as well as TGFβ levels, were increased in response to radiation, thus turning an immunologically “cold” tumor into a “hot” tumor, which may translate into better response to immunotherapy (58). The gene discussed is CTLA4; the disease is neoplasm.